Lisa Bradley
Medical · Los Angeles, CANPI 1427106764
Payments from drug & device makers
Across 58 payments — averaging $31.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$354
- E.r. Squibb & Sons, L.L.C.$194
- Novartis$168
- Incyte Corporation$128
- Otsuka America Pharmaceutical, Inc.$123
- Johnson & Johnson$104
- plus $747 from 22 others
What the payments were for
- Food & beverage$1,73395%
- Education$855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $354 |
| E.r. Squibb & Sons, L.L.C. | 9 | $194 |
| Novartis | 6 | $168 |
| Incyte Corporation | 5 | $128 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Johnson & Johnson | 2 | $104 |
| Global Blood Therapeutics, Inc. | 4 | $87 |
| Progenics Pharmaceuticals, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Abbott | 2 | $45 |
| Merck | 2 | $43 |
| Exelixis Inc. | 1 | $38 |
| Jazz Pharmaceuticals Inc. | 1 | $34 |
| AVEO Pharmaceuticals, Inc. | 1 | $32 |
| Genentech USA, Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Sobi, Inc | 1 | $23 |
| Pharmaessentia USA Corporation | 1 | $23 |
| GSK | 1 | $22 |
| Pfizer | 1 | $22 |
| Sanofi | 1 | $21 |
| Bayer | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Spectrum Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,818 in reported general payments places this provider in the 70th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atrovent HfaIpratropium Bromide | 11 | $5,445 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $4,090 |
| Tamsulosin Hcl | 19 | $490 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $342 |
| Amlodipine Besylate | 41 | $184 |
| Hydrochlorothiazide | 24 | $175 |
| Atorvastatin Calcium | 18 | $153 |
| Losartan Potassium | 11 | $143 |
| Omeprazole | 15 | $118 |
| Levothyroxine Sodium | 17 | $110 |
| Triamcinolone Acetonide | 11 | $107 |
| Metformin Hcl | 15 | $83 |
| Simvastatin | 18 | $79 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 14 | $65 |
| Naproxen | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKIncruse Ellipta | $22 | $4,09011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 medical providers in California.
Other medical in Los Angeles
- Jeffrey BonnaudLos Angeles$314K
- Kenny Davis TrinidadLos Angeles$99K
- Cheiny ShiauLos Angeles$86K
- Xochitl RentelnLos Angeles$38K
- Charlotte CarlsonLos Angeles$30K
- Dorna YaghoobzadehLos Angeles$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.